TD Securities last night downgraded Celestica (CLS) to Hold from Buy with a price target of $238, up from $130, after resuming coverage of the name. The firm is “impressed” with the company’s ...

Celestica’s AI-driven rally continues, but valuation and concentration risks make new entries risky. Find out why CLS stock ...

Complete Laboratory Solutions (CLS) has announced plans to create up to 140 new impact driven roles at their Galway City ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.

WAYNE, PA & ORLANDO, FL — Connect Life Sciences (CLS), a portfolio company of Argosy Healthcare Partners (AHP), has appointed ...